🔎 Trials Near Me

Home › Stomach Cancer › Washington

Stomach Cancer clinical trials in Washington

14 studies for Stomach Cancer are looking for participants at sites in Washington.

Cities in Washington

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Madigan Army Medical Center, Tacoma
RecruitingHealthy volunteers welcome
Ages 45 to 75 · All sexes · Updated Oct 5, 2026 · NCT06995898

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

  • Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07283939

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Providence Regional Cancer System-Aberdeen, Aberdeen
  • PeaceHealth Saint Joseph Medical Center, Bellingham
  • Providence Regional Cancer System-Centralia, Centralia
  • and 19 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

  • Harborview Medical Center, Seattle
  • Fred Hutchinson Cancer Center, Seattle
  • University of Washington Medical Center, Seattle
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07392892

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

  • Northwest Medical Specialties, Tacoma
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06047379

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

  • Research Site, Edmonds
  • Research Site, Issaquah
  • Research Site, Olympia
  • and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07431281

A Phase 1/1b Study of IAM1363 in HER2 Cancers

  • Fred Hutchinson Cancer Center, Seattle
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06253871

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

  • Fred Hutchinson Cancer Center, Seattle
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 13, 2026 · NCT07066657

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

  • Georgetown University Medical Center, Georgetown
  • Cancer Care Northwest, Spokane
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 29, 2026 · NCT03526835

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

  • Northwest Medical Specialities. PLLC, Bonney Lake
  • Swedish Cancer Institute - Edmonds Campus, Edmonds
  • Swedish Cancer Institute Edmonds Campus, Edmonds
  • and 9 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 6, 2026 · NCT04389632

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

  • Fred Hutchinson Cancer Center, Seattle
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Mar 27, 2026 · NCT06395519

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

  • American Oncology Network Vista Oncology Division, Olympia
  • Northwest Medical Specialties, Tacoma
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Feb 27, 2026 · NCT06532006

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Seattle
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

A Study of NX-1607 in Adults With Advanced Malignancies

  • Fred Hutchinson Cancer Center, Seattle
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2025 · NCT05107674

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.